hydroxychloroquine has been researched along with Myxedema in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.
Excerpt | Relevance | Reference |
---|---|---|
" The antimalarial hydroxychloroquine has a rapid and reliable effect in reticular erythematous mucinosis." | 3.72 | Treatment of scleromyxoedema with hydroxychloroquine. ( Becker, JC; Bröcker, EB; Kahaly, GJ; Lurz, C; Terheyden, P, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Terheyden, P | 1 |
Becker, JC | 1 |
Lurz, C | 1 |
Kahaly, GJ | 1 |
Bröcker, EB | 1 |
1 other study available for hydroxychloroquine and Myxedema
Article | Year |
---|---|
Treatment of scleromyxoedema with hydroxychloroquine.
Topics: Adult; Dermatologic Agents; Erythema; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Myxedem | 2003 |